By 2030, 70% of all new cancer diagnoses will be in older adults (≥65 years), reflecting a growing need for oncologic care paradigms that address the unique needs of older adults. 1 This is ...
MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S. commercial launch of PROSTOX™ Standard, a new, clinically validated genetic ...
Designing and Validating a Comprehensive Patient-Reported Outcomes Measure for Ambulatory Cancer Settings: The Revised Edmonton Symptom Assessment System for Cancer We retrospectively analyzed ...
Robotic surgery has revolutionized the field of genitourinary surgery over the past two decades, providing new possibilities for precision, minimally ...
Genitourinary disorders are conditions that affect the genitourinary system, which includes the urinary and reproductive systems. Some are congenital, and others are acquired later in life. There are ...
Dr. Maluf emphasized that his discussion would focus on penile squamous cell carcinoma and genitourinary basket trials. At ASCO 2024, Dr. Maluf presented the HERCULES (LACOG 0218), a phase II trial of ...
FORT MYERS, Fla., Feb. 26, 2026 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) advances genitourinary cancer treatment through participation at the global ASCO® 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results